Inventor
WATANABE KYOICHI A
US32 patents
⚠️ This page may combine multiple inventors who share the name “WATANABE KYOICHI A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SLOAN KETTERING INST CANCER
21 patentsUS4751221AJun 14, 1988
2-fluoro-arabinofuranosyl purine nucleosides
SLOAN KETTERING INST CANCER84 citations96
US5246924ASep 21, 1993
Method for treating hepatitis B virus infections using 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil
SLOAN KETTERING INST CANCER104 citations95
US4594339AJun 10, 1986
Anti-herpes virus compositions containing 5-substituted 1-2'(deoxy-2-'-substituted-β-d-arabinofuranosyl)pyrimedene nucleosides
SLOAN KETTERING INST CANCER68 citations95
US4211773AJul 8, 1980
5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
SLOAN KETTERING INST CANCER101 citations95
US4918179AApr 17, 1990
2'-fluoro-arabinofuranosyl purine nucleosides
SLOAN KETTERING INST CANCER36 citations92
US5700786ADec 23, 1997
Analogues of adenosine 5'diphosphate and pharmaceutical compositions thereof
SLOAN KETTERING INST CANCER28 citations88
US5569650AOct 29, 1996
C-nucleoside isosters of analogs thereof and pharmaceutical compositions
SLOAN KETTERING INST CANCER22 citations88
US5658890AAug 19, 1997
C-nucleoside isostere of nicotinamide adenine dinucleotide, analogs thereof and use as anti-cancer agent
SLOAN KETTERING INST CANCER26 citations85
US4762823AAug 9, 1988
Nucleosides of 5-monofluoromethyluracil and 5-difluoromethyluracil
SLOAN KETTERING INST CANCER24 citations80
US5053431AOct 1, 1991
Derivatives of chrysophanol as topoisomerase II inhibitors
SLOAN KETTERING INST CANCER15 citations74
US4966918AOct 30, 1990
Derivatives of chryosphanol
SLOAN KETTERING INST CANCER13 citations74
US5229395AJul 20, 1993
Potential anticancer agents derived from acridine
SLOAN KETTERING INST CANCER8 citations73
US5571937ANov 5, 1996
Complementary DNA and toxins
SLOAN KETTERING INST CANCER7 citations71
US5354864AOct 11, 1994
3-(9-acridinylamino)-5-hydroxymethylaniline derivatives as anticancer agents
SLOAN KETTERING INST CANCER11 citations69
US5476952ADec 19, 1995
Antitumor cyclopentnaphthoquinone and cyclopentanthraquinone derivatives
SLOAN KETTERING INST CANCER10 citations68
US5112869AMay 12, 1992
Substituted 1-phenylnaphthalenes
SLOAN KETTERING INST CANCER15 citations68
US4925939AMay 15, 1990
6,7-dihydropyrrol[3,4-c]pyrido[2,3-d]pyrimidine derivatives
SLOAN KETTERING INST CANCER5 citations63
US5296602AMar 22, 1994
Multisubstituted 1-hydroxy-9-acridones with anticancer activity
SLOAN KETTERING INST CANCER2 citations62
US5652350AJul 29, 1997
Complementary DNA and toxins
SLOAN KETTERING INST CANCER2 citations60
US5750675AMay 12, 1998
2'-"up" fluorinated 2'-deoxy-arabinofuranosylpurines
SLOAN KETTERING INST CANCER2 citations56
US5525720AJun 11, 1996
Synthesis of 2'-"up" fluorinated 2'-deoxy-arabinofuranosyl purines
SLOAN KETTERING INST CANCER1 citations45
PHARMASSET LTD
4 patentsUS7094770B2Aug 22, 2006
3′-or 2′-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
PHARMASSET LTD146 citations93
US6713623B2Mar 30, 2004
Tetraphosphonate bicyclic trisanhydrides
PHARMASSET LTD14 citations90
US6855821B2Feb 15, 2005
Processes for preparing 1,3-dioxolane nucleosides
PHARMASSET LTD7 citations73
US6326490B1Dec 4, 2001
Tetraphosphonate bicyclic trisanhydrides
PHARMASSET LTD5 citations71